NCT04370509 2025-11-19
Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery
University of California, San Francisco
Phase 2 Terminated
University of California, San Francisco
UMC Utrecht
University of Regensburg
Masonic Cancer Center, University of Minnesota
University Hospital, Gasthuisberg